Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Moderate to Severe Rheumatoid Arthritis Study (RA-BEACON)

This study has been completed.
Information provided by (Responsible Party):
Eli Lilly and Company Identifier:
First received: November 1, 2012
Last updated: September 29, 2014
Last verified: September 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2014
  Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: September 29, 2014